Search - tctmd.com

Displaying 981 - 1000 of 1095

Sort: Relevancy | Date

News Daily News

SYNTAX: Stent Thrombosis Has Greater Impact on Mortality Than Graft Occlusion

Leah Lawrence

October 25, 2013

News Daily News

CADUCEUS: Células madre autólogas revierten de manera segura algunos daños del IM

September 27, 2013

News Daily News

CADUCEUS: Autologous Stem Cells Safely Reverse Some MI Damage

September 27, 2013

News Daily News

Analysis Strengthens Support for Enoxaparin Over Heparin in PCI for STEMI

L.A. McKeown

September 20, 2013

News Daily News

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Yael L. Maxwell

August 23, 2013

News Daily News

Subestudio del TRILOGY ACS: El Prasugrel Post-Angiografía Minimiza el Riesgo de Episodios Adversos

Yael L. Maxwell

August 23, 2013

News Daily News

Swedish, Canadian Registries: Women Less Likely to Be Reperfused After STEMI

Yael L. Maxwell

August 05, 2013

News Daily News

Meta-Analysis: Increased MI Risk with Double Bifurcation Stenting Due in Part to Stent Thrombosis

July 24, 2013

News Daily News

Un Fármaco Reductor de la Frecuencia Cardíaca resulta Prometedor para Pacientes STEMI tras PCI

L.A. McKeown

July 19, 2013

News Daily News

Heart Rate-Lowering Drug Shows Promise for STEMI Patients After PCI

L.A. McKeown

July 19, 2013

News Daily News

PCI Use, Survival Higher in US Elderly AMI Patients vs. Sweden

L.A. McKeown

July 11, 2013

News Daily News

El Uso de PCI y la Supervivencia es Mayor en Pacientes Ancianos víctimas de IAM en EE.UU. que en Suecia

L.A. McKeown

July 11, 2013

News Daily News

REOPEN-AMI Published: Adenosine Reduces ‘No-Reflow’ in STEMI Patients

July 05, 2013

News Daily News

REOPEN-AMI Publicado: La Adenosina Reduce la ‘Ausencia de Reflujo’ en Pacientes STEMI

July 05, 2013

News Daily News

Prasugrel Noninferior to Ticagrelor in STEMI, but Both Require Hours to Achieve Effect

Yael L. Maxwell

May 13, 2013

News Daily News

Prasugrel No es Inferior al Ticagrelor en los cuadros de STEMI, aunque Deben pasar Horas hasta que Ambos Hagan Efecto

Yael L. Maxwell

May 13, 2013

News Daily News

Las Células Madre de la Médula Ósea No son Efectivas Antes ni Después de sufrir un IAM

Jason Kahn

April 26, 2013

News Daily News

Bone Marrow Stem Cells Not Effective Early or Late After AMI

Jason Kahn

April 26, 2013

News Daily News

Vorapaxar Substudy Shows Broad MI Reduction in High-Risk ACS Patients

L.A. McKeown

April 19, 2013

News Daily News

Un Subestudio del Vorapaxar revela un Amplio Descenso de IM en Pacientes SCA de Alto Riesgo

L.A. McKeown

April 19, 2013

Advertisement

SYNTAX: Stent Thrombosis Has Greater Impact on Mortality Than Graft Occlusion

CADUCEUS: Células madre autólogas revierten de manera segura algunos daños del IM

CADUCEUS: Autologous Stem Cells Safely Reverse Some MI Damage

Analysis Strengthens Support for Enoxaparin Over Heparin in PCI for STEMI

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Subestudio del TRILOGY ACS: El Prasugrel Post-Angiografía Minimiza el Riesgo de Episodios Adversos

Swedish, Canadian Registries: Women Less Likely to Be Reperfused After STEMI

Meta-Analysis: Increased MI Risk with Double Bifurcation Stenting Due in Part to Stent Thrombosis

Un Fármaco Reductor de la Frecuencia Cardíaca resulta Prometedor para Pacientes STEMI tras PCI

Heart Rate-Lowering Drug Shows Promise for STEMI Patients After PCI

PCI Use, Survival Higher in US Elderly AMI Patients vs. Sweden

El Uso de PCI y la Supervivencia es Mayor en Pacientes Ancianos víctimas de IAM en EE.UU. que en Suecia

REOPEN-AMI Published: Adenosine Reduces ‘No-Reflow’ in STEMI Patients

REOPEN-AMI Publicado: La Adenosina Reduce la ‘Ausencia de Reflujo’ en Pacientes STEMI

Prasugrel Noninferior to Ticagrelor in STEMI, but Both Require Hours to Achieve Effect

Prasugrel No es Inferior al Ticagrelor en los cuadros de STEMI, aunque Deben pasar Horas hasta que Ambos Hagan Efecto

Las Células Madre de la Médula Ósea No son Efectivas Antes ni Después de sufrir un IAM

Bone Marrow Stem Cells Not Effective Early or Late After AMI

Vorapaxar Substudy Shows Broad MI Reduction in High-Risk ACS Patients

Un Subestudio del Vorapaxar revela un Amplio Descenso de IM en Pacientes SCA de Alto Riesgo

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content